腺苷酸环化酶1抗体
3'5' cyclic AMP synthetase; ADCY1; adenyl cyclase; Adenylate cyclase 1; adenylate cyclase type I; ATP pyrophosphate lyase; Brain adenylate cyclase 1; Ca(2+)/calmodulin activated adenylyl cyclase; EC 4
富含亮氨酸重复结构域蛋白9抗体
LRR and PYD domains-containing protein 9; NACHT; NACHT, LRR and PYD domains-containing protein 9; NALP9_HUMAN; NLRP9; Nucleotide-binding oligomerization domain protein 6; PYRIN and NACHT-containing pr
细胞色素C P450 17A1抗体
20 lyase; CP17A_HUMAN; CPT7; CYP17; CYP17A1; CYPXVII; Cytochrome P450 17A1; Cytochrome P450 family 17; Cytochrome P450 family 17 subfamily A polypeptide 1; Cytochrome p450 XVIIA1; Cytochrome p450, sub
滤泡型转运蛋白1/II型慢性淋巴性白血病抗体
3 dehydrosphinganine reductase; 3 ketodihydrosphingosine reductase; 3-dehydrosphinganine reductase; 3-ketodihydrosphingosine reductase; DHSR; FLJ36555; FLJ92680; Follicular lymphoma variant translocat
Anti-HYAL1 Polyclonal Antibody
Anti-HYAL1 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human